NASDAQ · RNAZ
TransCode Therapeutics, Inc.
Healthcare · Biotechnology
$1.60
Up+$0.03 (+1.91%)
Updated Nov 5, 2026, 5:46 AM
SID Score
3.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.55M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $1.50 – $12.69
- Volume
- 7.1K
- Avg. volume
- 142.25K
Price performance · RNAZ
RNAZ price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
RNAZ closed at $1.60 after 21 trading sessions, down 9.09% for the selected period.
- Last close
- $1.60
- Period change
- -9.09%
- Period low
- $1.57
- Period high
- $1.86
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $1.61 | $1.7198 | $1.57 | $1.60 | 7.1K |
| Nov 3, 2026 | $1.60 | $1.65 | $1.50 | $1.57 | 29.55K |
| Nov 2, 2026 | $1.69 | $1.69 | $1.61 | $1.63 | 16.52K |
| Oct 30, 2026 | $1.73 | $1.785 | $1.62 | $1.63 | 16.19K |
| Oct 29, 2026 | $1.837 | $1.91 | $1.73 | $1.73 | 40.84K |
| Oct 28, 2026 | $1.61 | $1.78 | $1.61 | $1.74 | 18.49K |
| Oct 27, 2026 | $1.71 | $1.7699 | $1.65 | $1.67 | 7.5K |
| Oct 26, 2026 | $1.78 | $1.78 | $1.70 | $1.7055 | 54.29K |
| Oct 23, 2026 | $1.65 | $1.84 | $1.65 | $1.77 | 32.68K |
| Oct 22, 2026 | $1.62 | $1.80 | $1.62 | $1.715 | 27.97K |
| Oct 21, 2026 | $1.69 | $1.8099 | $1.65 | $1.66 | 16.75K |
| Oct 20, 2026 | $1.71 | $1.75 | $1.6025 | $1.68 | 20.23K |
| Oct 19, 2026 | $1.70 | $1.8399 | $1.66 | $1.70 | 29.31K |
| Oct 16, 2026 | $1.83 | $1.8637 | $1.695 | $1.70 | 29.02K |
| Oct 15, 2026 | $1.7896 | $1.8999 | $1.71 | $1.80 | 35.31K |
| Oct 14, 2026 | $1.74 | $1.82 | $1.67 | $1.73 | 43.24K |
| Oct 13, 2026 | $1.67 | $1.7799 | $1.668 | $1.68 | 54.45K |
| Oct 12, 2026 | $1.91 | $1.91 | $1.63 | $1.63 | 31.93K |
| Oct 9, 2026 | $1.78 | $1.95 | $1.74 | $1.86 | 84.08K |
| Oct 8, 2026 | $1.80 | $1.80 | $1.675 | $1.71 | 27.84K |
| Oct 7, 2026 | $1.78 | $1.79 | $1.67 | $1.76 | 29.76K |
Latest RNAZ news
The latest Smart Investors Daily articles mentioning RNAZ.
Stock researchMarket Activity · Sentiment
Company
Market Activity
Research & News

